Search research articles
Contact Us
Filters
Showing results (21-30 of 276) with videos related to
Page
of 28
Sort By:
Cancer
|
February 4, 2009
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Gynecologic Oncology
|
December 23, 2015
Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prognostic factors for complete debulking in first- and second-line ovarian cancer
Philipp Harter, Felix Hilpert, Sven Mahner, et al.
Cancer
|
January 22, 2009
Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients
Christian Walter, Bilal Al-Nawas, Andreas du Bois, et al.
Gynecologic Oncology
|
October 15, 2014
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Virchows Archiv : an International Journal of Pathology
|
January 28, 2009
Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)
Stefan Kommoss, Dietmar Schmidt, Friedrich Kommoss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials
Andreas du Bois, Alexander Reuss, Philipp Harter, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
November 11, 2009
Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary
Benjamin Kasenda, Philipp Harter, Tobias Hirsch, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 15, 2009
Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva
Patriciu Achimas-Cadariu, Philipp Harter, Annette Fisseler-Eckhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 14, 2009
Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study
Ruth Gomez, Philipp Harter, Hans-Joachim Lück, et al.
Page
of 28
Search research articles
Search
Showing results (21-30 of 276) with videos related to
Sort By:
Page
of 28
Cancer
|
February 4, 2009
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Gynecologic Oncology
|
December 23, 2015
Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prognostic factors for complete debulking in first- and second-line ovarian cancer
Philipp Harter, Felix Hilpert, Sven Mahner, et al.
Cancer
|
January 22, 2009
Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients
Christian Walter, Bilal Al-Nawas, Andreas du Bois, et al.
Gynecologic Oncology
|
October 15, 2014
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer
Beyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Virchows Archiv : an International Journal of Pathology
|
January 28, 2009
Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)
Stefan Kommoss, Dietmar Schmidt, Friedrich Kommoss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials
Andreas du Bois, Alexander Reuss, Philipp Harter, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
November 11, 2009
Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary
Benjamin Kasenda, Philipp Harter, Tobias Hirsch, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 15, 2009
Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva
Patriciu Achimas-Cadariu, Philipp Harter, Annette Fisseler-Eckhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 14, 2009
Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study
Ruth Gomez, Philipp Harter, Hans-Joachim Lück, et al.
Page
of 28